Goff Stephanie L, Rosenberg Steven A
Surgery Branch, National Cancer Institute Center for Cancer Research, Bethesda, Maryland, USA
Surgery Branch, National Cancer Institute Center for Cancer Research, Bethesda, Maryland, USA.
J Immunother Cancer. 2025 Apr 9;13(4):e011734. doi: 10.1136/jitc-2025-011734.
The early development of tumor-infiltrating lymphocytes into an effective clinical strategy was fundamentally the work of hundreds of scientists and clinicians within the Surgery Branch of the National Cancer Institute under the leadership of Steven Rosenberg. That journey brought new insights into the tumor-immune cell interface and ultimately helped create a new first-in-class therapeutic for patients with metastatic cancer.
肿瘤浸润淋巴细胞早期发展成为一种有效的临床策略，从根本上来说是在史蒂文·罗森伯格的领导下，美国国立癌症研究所外科分部数百名科学家和临床医生的工作成果。这一历程为肿瘤与免疫细胞的界面带来了新的见解，并最终帮助为转移性癌症患者开发出了一种全新的一流疗法。
